Skip to main content

Table 2 Demographic characteristics of patients included in the ADPKD study cohorts

From: Mortality risk in patients with autosomal dominant polycystic kidney disease

Characteristics

Non-ESRD CKD study cohort (N = 1,936)

ESRD study cohort

(N = 37,461)

Age

 Mean (SD)

71.4 (13.2)

59.2 (11.8)

 Median

72.0

59.0

 Min, max

2, 107

0, 99

Age group, n (%)

 < 18 years

2 (0.1%)

38 (0.1%)

 18–24 years

3 (0.2%)

133 (0.4%)

 25–34 years

26 (1.3%)

683 (1.8%)

 35–44 years

48 (2.5%)

2,915 (7.8%)

 45–54 years

138 (7.1%)

8,756 (23.4%)

 55–64 years

178 (9.2%)

12,728 (34.0%)

 65–74 years

688 (35.5%)

8,635 (23.1%)

 75–84 years

564 (29.1%)

3,060 (8.2%)

 85 years and older

289 (14.9%)

513 (1.4%)

Sex, n (%)

 Male

1,030 (53.2%)

19,999 (53.4%)

 Female

906 (46.8%)

17,462 (46.6%)

Race, n (%)

 White

1,542 (79.6%)

27,637 (73.8%)

 Black

271 (14.0%)

4,504 (12.0%)

 Hispanic

36 (1.9%)

3,924 (10.5%)

 Asian

36 (1.9%)

1,018 (2.7%)

 Other or unknown a

51 (2.6%)

378 (1.0%)

  1. ADPKD Autosomal dominant polycystic kidney disease, CKD Chronic kidney disease, ESRD End-stage renal disease, SD Standard deviation, USRDS United States Renal Data System
  2. aIn addition to “White,” “Black,” “Hispanic,” and “Asian” in the non-ESRD CKD USRDS dataset, “race” also included “Native American,” “Other,” and “Unknown,” which have been grouped in this table as “Other or unknown.” In addition to “White,” “Black/African American” (referred to as “Black” in this table), “Hispanic,” and “Asian” in the ESRD USRDS dataset, “race” also included “American Indian or Alaska Native,” “Native Hawaiian or Pacific Islander,” “Other or Multiracial,” and Unknown, which have been grouped in this table as “Other or unknown.”